| Dr Craig Hudgins Phillips, MD | |
|
67 Riverton Commons Dr, Front Royal, VA 22630-6768 | |
| (540) 635-0848 | |
| Not Available |
| Full Name | Dr Craig Hudgins Phillips |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 67 Riverton Commons Dr, Front Royal, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043229412 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 67308 (Georgia) | Secondary |
| 207Q00000X | Family Medicine | 0101255950 (Virginia) | Primary |
| Entity Name | Warren Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164442281 PECOS PAC ID: 2365330347 Enrollment ID: O20040310000516 |
News Archive
Scientists have revealed the intricate structure of cartilage in what they hope will provide clues to how the crippling joint disease osteoarthritis might one day be treated.
A new study by researchers at Wake Forest University School of Medicine may reveal how long-lasting memories form in the brain.
Today Senate Majority Leader Harry Reid (D-Nev.) released his long awaited "manager's amendment" with new language dealing with the abortion issue. The new language is being trumpeted as including an opt-out provision that actually makes the opt-out provision in the original bill worse by requiring the state to either cover all abortions or opt out of all abortions.
VION PHARMACEUTICALS, INC. announced today that it had filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase II/III trial of its oncology therapeutic Onrigin™ (laromustine) Injection in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML). The primary objective for the Phase III part of this study is to determine if Onrigin™ plus LDAC improves overall survival compared with LDAC alone.
Use of a device and system to clear dislodged "debris" during percutaneous interventions to open a blocked artery following a heart attack does not appear to be clinically beneficial, according to a study in the March 2 issue of JAMA.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Craig Hudgins Phillips, MD 67 Riverton Commons Dr, Front Royal, VA 22630-6768 Ph: (540) 635-0848 | Dr Craig Hudgins Phillips, MD 67 Riverton Commons Dr, Front Royal, VA 22630-6768 Ph: (540) 635-0848 |
News Archive
Scientists have revealed the intricate structure of cartilage in what they hope will provide clues to how the crippling joint disease osteoarthritis might one day be treated.
A new study by researchers at Wake Forest University School of Medicine may reveal how long-lasting memories form in the brain.
Today Senate Majority Leader Harry Reid (D-Nev.) released his long awaited "manager's amendment" with new language dealing with the abortion issue. The new language is being trumpeted as including an opt-out provision that actually makes the opt-out provision in the original bill worse by requiring the state to either cover all abortions or opt out of all abortions.
VION PHARMACEUTICALS, INC. announced today that it had filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase II/III trial of its oncology therapeutic Onrigin™ (laromustine) Injection in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML). The primary objective for the Phase III part of this study is to determine if Onrigin™ plus LDAC improves overall survival compared with LDAC alone.
Use of a device and system to clear dislodged "debris" during percutaneous interventions to open a blocked artery following a heart attack does not appear to be clinically beneficial, according to a study in the March 2 issue of JAMA.
› Verified 9 days ago
Jeffery Groesbeck, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 351 Valley Health Way # 300, Front Royal, VA 22630 Phone: 540-631-3700 | |
Trieu Thi-hai Vo, Family Medicine Medicare: Medicare Enrolled Practice Location: 351 Valley Health Way Ste 300, Front Royal, VA 22630 Phone: 540-631-3700 | |
Claudine Nigro, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 140 W 11th St, Front Royal, VA 22630 Phone: 949-274-5593 | |
Samuel Woo Lee, Family Medicine Medicare: Medicare Enrolled Practice Location: 351 Valley Health Way Ste 300, Front Royal, VA 22630 Phone: 540-631-3700 Fax: 540-635-1673 | |
Candace Jill Wise, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 351 Valley Health Way # 300, Front Royal, VA 22630 Phone: 540-631-3700 | |
Dr. Tamara Denise Spriggs, MD, MPH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 140 W 11th St, Front Royal, VA 22630 Phone: 540-631-3700 Fax: 540-635-1673 |